Communicating with patients: What should we tell them about pathophysiology?

(1) Italy



This item was part of the Medical Gastroenterology III Practical management of patients with functional GI disorders session at UEG Week Stockholm 2011

You may be interested in:

ALFASIGMA - A worldwide perspective on diagnosis and management of diverticular disease: understanding similarities and differences (ALFASIGMA S.p.A)
English, Presentation, Industry Sponsored Symposia, Industry Sponsored Symposia, 2018, Alfasigma S.p.A.
MUCOSAL IMMUNE BIOMARKERS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME
English, Irritable Bowel Syndrome, Brain-gut and gut-brain axes, neuro-hormonal, neuralimmune and visceral sensitivity, Abstract, 2013

Categorisation:

  • Format
    • Syllabus contribution
  • Language
    • English
  • Year
    • 2011